keyword
https://read.qxmd.com/read/38465655/dietary-lipoic-acid-alleviates-autism-like-behavior-induced-by-acrylamide-in-adolescent-mice-the-potential-involvement-of-the-gut-brain-axis
#21
JOURNAL ARTICLE
Jin Ye, Hua Fan, Renjie Shi, Ge Song, Xiaoning Wu, Danna Wang, Bing Xia, Zhenting Zhao, Beita Zhao, Xuebo Liu, Yutang Wang, Xiaoshuang Dai
Consuming fried foods has been associated with an increased susceptibility to mental health disorders. Nevertheless, the impact of alpha-lipoic acid (α-LA, LA) on fried food-induced autism-like behavior remains unclear. This study aimed to explore how LA affects autism-related behavior and cognitive deficits caused by acrylamide in mice, a representative food hazard found in fried foods. This improvement was accomplished by enhanced synaptic plasticity, increased neurotrophin expression, elevated calcium-binding protein D28k, and restored serotonin...
March 11, 2024: Food & Function
https://read.qxmd.com/read/38455067/combined-repetitive-transcranial-magnetic-stimulation-and-gut-microbiota-modulation-through-the-gut-brain-axis-for-prevention-and-treatment-of-autism-spectrum-disorder
#22
REVIEW
Pengya Feng, Yangyang Zhang, Yonghong Zhao, Pengju Zhao, Enyao Li
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental conditions characterized by enduring impairments in social communication and interaction together with restricted repetitive behaviors, interests, and activities. No targeted pharmacological or physical interventions are currently available for ASD. However, emerging evidence has indicated a potential association between the development of ASD and dysregulation of the gut-brain axis. Repetitive transcranial magnetic stimulation (rTMS), a noninvasive diagnostic and therapeutic approach, has demonstrated positive outcomes in diverse psychiatric disorders; however, its efficacy in treating ASD and its accompanying gastrointestinal effects, particularly the effects on the gut-brain axis, remain unclear...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38435887/enteric-dysbiosis-in-children-with-autism-spectrum-disorder-and-associated-response-to-stress
#23
JOURNAL ARTICLE
Gesulla Cavanaugh, Jinbing Bai, Jaime L Tartar, Jue Lin, Tina Nunn, Naseer Sangwan, Diti Patel, Stachyse Stanis, Raina K Patel, Djellza Rrukiqi, Hannah Murphy
Background Microbiome studies in humans, though limited, have facilitated the evaluation of the potential connection between the microbiome and brain function. Children with autism spectrum disorder (ASD) have several behavioral challenges and avoidant/restrictive food intake disorder, which may contribute to gut microbiome dysbiosis. Aim The aim of this study is to examine the extent to which the gut microbiome of children with ASD differs in comparison to children with neurotypical development (CWND) and to assess whether a probiotic intervention has the potential to influence the gut microbiome in mediating positive behavior change and stress regulation...
January 2024: Curēus
https://read.qxmd.com/read/38434761/autism-spectrum-disorder-pathogenesis-biomarker-and-intervention-therapy
#24
REVIEW
Hongbin Zhuang, Zhiyuan Liang, Guanwei Ma, Ayesha Qureshi, Xiaoqian Ran, Chengyun Feng, Xukun Liu, Xi Yan, Liming Shen
Autism spectrum disorder (ASD) has become a common neurodevelopmental disorder. The heterogeneity of ASD poses great challenges for its research and clinical translation. On the basis of reviewing the heterogeneity of ASD, this review systematically summarized the current status and progress of pathogenesis, diagnostic markers, and interventions for ASD. We provided an overview of the ASD molecular mechanisms identified by multi-omics studies and convergent mechanism in different genetic backgrounds. The comorbidities, mechanisms associated with important physiological and metabolic abnormalities (i...
March 2024: MedComm
https://read.qxmd.com/read/38428908/causal-effects-of-gut-microbiota-on-autism-spectrum-disorder-a-two-sample-mendelian-randomization-study
#25
JOURNAL ARTICLE
Yajun Chen, Yan Xue, Lang Jia, Menghan Yang, Gelin Huang, Jiang Xie
There is increasing evidence that alterations in gut microbiota (GM) composition are associated with autism spectrum disorder (ASD), but no reliable causal relationship has been established. Therefore, a 2-sample Mendelian randomization (MR) study was conducted to reveal a potential causal relationship between GM and ASD. Instrumental variables for 211 GM taxa were obtained from genome-wide association studies (GWAS) and Mendelian randomization studies to estimate their impact on ASD risk in the iPSYCH-PGC GWAS dataset (18,382 ASD cases and 27,969 controls)...
March 1, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38419294/a-comprehensive-diversity-analysis-on-the-gut-microbiomes-of-asd-patients-from-alpha-beta-to-gamma-diversities
#26
JOURNAL ARTICLE
Hongju Daisy Chen, Lianwei Li, Fubing Yu, Zhanshan Sam Ma
Autism spectrum disorder (ASD) is estimated to influence as many as 1% children worldwide, but its etiology is still unclear. It has been suggested that gut microbiomes play an important role in regulating abnormal behaviors associated with ASD. A de facto standard analysis on the microbiome-associated diseases has been diversity analysis, and nevertheless, existing studies on ASD-microbiome relationship have not produced a consensus. Here, we perform a comprehensive analysis of the diversity changes associated with ASD involving alpha-, beta-, and gamma-diversity metrics, based on 8 published datasets consisting of 898 ASD samples and 467 healthy controls (HC) from 16S-rRNA sequencing...
February 28, 2024: FEMS Microbiology Letters
https://read.qxmd.com/read/38413544/crass-like-phages-from-discovery-in-human-fecal-metagenome-to-application-as-a-microbial-source-tracking-marker
#27
REVIEW
Arun Thachappully Remesh, Rajlakshmi Viswanathan
CrAss-like phages are a diverse group of bacteriophages genetically similar to the prototypical crAssphage (p-crAssphage), which was discovered in the human gut microbiome through a metagenomics approach. It was identified as a ubiquitous and highly abundant bacteriophage group in the gut microbiome. Initial co-occurrence analysis postulated Bacteroides spp. as the prospective bacterial host. Subsequent studies have confirmed multiple host species under Phylum Bacteroidetes and some Firmicutes. Detection of crAss-like phages in sewage-contaminated environmental water and robust correlation with enteric viruses and bacteria has culminated in their adoption as a microbial source tracking (MST) marker...
February 27, 2024: Food and Environmental Virology
https://read.qxmd.com/read/38410675/a-bibliometric-analysis-of-autism-spectrum-disorder-signaling-pathways-research-in-the-past-decade
#28
JOURNAL ARTICLE
Kaifeng Lyu, Jiangshan Li, Min Chen, Wu Li, Wei Zhang, Meichao Hu, Yuxing Zhang, Xiang Feng
BACKGROUND: This study employs bibliometric methods to comprehensively understand the fundamental structure of research about Autism Spectrum Disorder (ASD) Signaling Pathways by examining key indicators such as nations, institutions, journals, authors, and keywords. METHODOLOGY: We utilized the WoScc database to retrieve literature relevant to ASD Signaling Pathways published between 2013 and 2023. Through visual analysis and tools like CiteSpace and VosViewer, we explored nations, institutions, journals, authors, and keywords, thereby constructing relevant networks...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38398876/dietary-and-metabolic-approaches-for-treating-autism-spectrum-disorders-affective-disorders-and-cognitive-impairment-comorbid-with-epilepsy-a-review-of-clinical-and-preclinical-evidence
#29
REVIEW
Shruthi H Iyer, Mary Y Yeh, Lauren Netzel, Molly G Lindsey, McKenzie Wallace, Kristina A Simeone, Timothy A Simeone
Epilepsy often occurs with other neurological disorders, such as autism, affective disorders, and cognitive impairment. Research indicates that many neurological disorders share a common pathophysiology of dysfunctional energy metabolism, neuroinflammation, oxidative stress, and gut dysbiosis. The past decade has witnessed a growing interest in the use of metabolic therapies for these disorders with or without the context of epilepsy. Over one hundred years ago, the high-fat, low-carbohydrate ketogenic diet (KD) was formulated as a treatment for epilepsy...
February 17, 2024: Nutrients
https://read.qxmd.com/read/38398873/between-dysbiosis-maternal-immune-activation-and-autism-is-there-a-common-pathway
#30
REVIEW
Maria Suprunowicz, Natalia Tomaszek, Agata Urbaniak, Klaudia Zackiewicz, Stefan Modzelewski, Napoleon Waszkiewicz
Autism spectrum disorder (ASD) is a neuropsychiatric condition characterized by impaired social interactions and repetitive stereotyped behaviors. Growing evidence highlights an important role of the gut-brain-microbiome axis in the pathogenesis of ASD. Research indicates an abnormal composition of the gut microbiome and the potential involvement of bacterial molecules in neuroinflammation and brain development disruptions. Concurrently, attention is directed towards the role of short-chain fatty acids (SCFAs) and impaired intestinal tightness...
February 16, 2024: Nutrients
https://read.qxmd.com/read/38375040/exploratory-focused-pharmacogenetic-testing-reveals-novel-markers-associated-with-risperidone-pharmacokinetics-in-saudi-children-with-autism
#31
JOURNAL ARTICLE
Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ezzeldeen Hasan Ghanem, Haya Aljurayb, Khawlah Essa Aldilaijan, Fatimah AlDosari, Abeer Fadda
Background: Autism spectrum disorders (ASDs) encompass a broad range of phenotypes characterized by diverse neurological alterations. Genomic studies have revealed considerable overlap between the molecular mechanisms implicated in the etiology of ASD and genes involved in the pharmacokinetic (PK) and pharmacodynamic (PD) pathways of antipsychotic drugs employed in ASD management. Given the conflicting data originating from candidate PK or PD gene association studies in diverse ethnogeographic ASD populations, dosage individualization based on "actionable" pharmacogenetic (PGx) markers has limited application in clinical practice...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38369656/gut-microbiome-and-serum-amino-acid-metabolome-alterations-in-autism-spectrum-disorder
#32
JOURNAL ARTICLE
Xuening Chang, Yuchen Zhang, Xue Chen, Shihan Li, Hong Mei, Han Xiao, Xinyu Ma, Zhisheng Liu, Ruizhen Li
Gut microbiota and their metabolic products might play important roles in regulating the pathogenesis of autism spectrum disorder (ASD). The purpose of this study was to characterize gut microbiota and serum amino acid metabolome profiles in children with ASD. A non-randomized controlled study was carried out to analyze the alterations in the intestinal microbiota and their metabolites in patients with ASD (n = 30) compared with neurotypical controls (NC) (n = 30) by metagenomic sequencing to define the gut microbiota community and liquid chromatography/mass spectrometry (LC/MS) analysis to characterize the metabolite profiles...
February 19, 2024: Scientific Reports
https://read.qxmd.com/read/38361371/investigating-the-impact-of-probiotic-on-neurological-outcomes-in-rett-syndrome-a-randomized-double-blind-and-placebo-controlled-pilot-study
#33
JOURNAL ARTICLE
Lee Chin Wong, Chia-Jui Hsu, Yen-Tzu Wu, Hsu-Feng Chu, Jui-Hsiang Lin, Hsin-Pei Wang, Su-Ching Hu, Ying-Chieh Tsai, Wen-Che Tsai, Wang-Tso Lee
Rett syndrome often involves gastrointestinal symptoms and gut microbiota imbalances. We conducted a study to explore the feasibility of probiotic Lactobacillus plantarum PS128 and the impact on neurological functions in Rett syndrome. The results of our investigation demonstrated that the supplementation of probiotic L. plantarum PS128 was feasible and well tolerated, with 100% retention rate and 0% withdrawal rate. In addition, there was only one participant who had loose stool after taking L. plantarum PS128...
February 15, 2024: Autism: the International Journal of Research and Practice
https://read.qxmd.com/read/38320845/protocol-for-the-gut-bugs-in-autism-trial-a-double-blind-randomised-placebo-controlled-trial-of-faecal-microbiome-transfer-for-the-treatment-of-gastrointestinal-symptoms-in-autistic-adolescents-and-adults
#34
JOURNAL ARTICLE
Ry Y Tweedie-Cullen, Karen Leong, Brooke C Wilson, José G B Derraik, Benjamin B Albert, Ruth Monk, Tommi Vatanen, Christine Creagh, Marysia Depczynski, Taygen Edwards, Kathryn Beck, Hiran Thabrew, Justin M O'Sullivan, Wayne S Cutfield
INTRODUCTION: Autism (formally autism spectrum disorder) encompasses a group of complex neurodevelopmental conditions, characterised by differences in communication and social interactions. Co-occurring chronic gastrointestinal symptoms are common among autistic individuals and can adversely affect their quality of life. This study aims to evaluate the efficacy of oral encapsulated faecal microbiome transfer (FMT) in improving gastrointestinal symptoms and well-being among autistic adolescents and adults...
February 6, 2024: BMJ Open
https://read.qxmd.com/read/38308741/a-population-pharmacokinetics-model-of-balovaptan-to-support-dose-selection-in-adult-and-pediatric-populations
#35
JOURNAL ARTICLE
Franziska Schaedeli Stark, Clarisse Chavanne, Michael Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
Balovaptan is a brain-penetrating vasopressin receptor 1a antagonist previously investigated for the core symptoms of autism spectrum disorder (ASD). A population pharmacokinetic (PK) model of balovaptan was developed, initially to assist clinical dosing for adult and pediatric ASD studies and subsequently for new clinical indications including malignant cerebral edema (MCE) and post-traumatic stress disorder. The final model incorporates one-compartment disposition and describes time- and dose-dependent non-linear PK through empirical drug binding and a gut extraction component with turnover...
February 3, 2024: Journal of Pharmacokinetics and Pharmacodynamics
https://read.qxmd.com/read/38307030/alterations-in-fecal-virome-and-bacteriome-virome-interplay-in-children-with-autism-spectrum-disorder
#36
JOURNAL ARTICLE
Yating Wan, Lin Zhang, Zhilu Xu, Qi Su, Ting-Fan Leung, Dorothy Chan, Oscar W H Wong, Sandra Chan, Francis K L Chan, Hein M Tun, Siew C Ng
Emerging evidence suggests autism spectrum disorder (ASD) is associated with altered gut bacteria. However, less is known about the gut viral community and its role in shaping microbiota in neurodevelopmental disorders. Herein, we perform a metagenomic analysis of gut-DNA viruses in 60 children with ASD and 64 age- and gender-matched typically developing children to investigate the effect of the gut virome on host bacteria in children with ASD. ASD is associated with altered gut virome composition accompanied by the enrichment of Clostridium phage, Bacillus phage, and Enterobacteria phage...
January 31, 2024: Cell reports medicine
https://read.qxmd.com/read/38306525/the-correlation-between-gut-microbiota-and-both-neurotransmitters-and-mental-disorders-a-narrative-review
#37
REVIEW
Amjad Mhanna, Nafiza Martini, Ghefar Hmaydoosh, George Hamwi, Mulham Jarjanazi, Ghaith Zaifah, Reem Kazzazo, Aya Haji Mohamad, Zuheir Alshehabi
The gastrointestinal tract is embedded with microorganisms of numerous genera, referred to as gut microbiota. Gut microbiota has multiple effects on many body organs, including the brain. There is a bidirectional connection between the gut and brain called the gut-brain-axis, and these connections are formed through immunological, neuronal, and neuroendocrine pathways. In addition, gut microbiota modulates the synthesis and functioning of neurotransmitters. Therefore, the disruption of the gut microbiota in the composition or function, which is known as dysbiosis, is associated with the pathogenesis of many mental disorders, such as schizophrenia, depression, and other psychiatric disorders...
February 2, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38296969/amelioration-of-the-brain-structural-connectivity-is-accompanied-with-changes-of-gut-microbiota-in-a-tuberous-sclerosis-complex-mouse-model
#38
JOURNAL ARTICLE
Christine Chin-Jung Hsieh, Yu-Chun Lo, Hsin-Hui Wang, Hsin-Ying Shen, You-Yin Chen, Yi-Chao Lee
Tuberous sclerosis complex (TSC) is a genetic disease that causes benign tumors and dysfunctions in many organs, including the brain. Aside from the brain malformations, many individuals with TSC exhibit neuropsychiatric symptoms. Among these symptoms, autism spectrum disorder (ASD) is one of the most common co-morbidities, affecting up to 60% of the population. Past neuroimaging studies strongly suggested that the impairments in brain connectivity contribute to ASD, whether or not TSC-related. Specifically, the tract-based diffusion tensor imaging (DTI) analysis provides information on the fiber integrity and has been used to study the neuropathological changes in the white matter of TSC patients with ASD symptoms...
January 31, 2024: Translational Psychiatry
https://read.qxmd.com/read/38291245/a-double-blind-randomised-controlled-trial-of-prebiotic-supplementation-in-children-with-autism-effects-on-parental-quality-of-life-child-behaviour-gastrointestinal-symptoms-and-the-microbiome
#39
JOURNAL ARTICLE
Jacqueline K Palmer, Jolieke C van der Pols, Karen A Sullivan, Heidi M Staudacher, Rebecca Byrne
PURPOSE: Modifying gut bacteria in children with autism may influence behaviour, with potential to improve family functioning. We conducted a randomised controlled trial to assess the effect of prebiotics on behaviour, gastrointestinal symptoms and downstream effects on parental quality of life. METHOD: Children with autism (4-10yrs) were randomised to 2.4 g/d of prebiotic (GOS) or placebo for six weeks. Pre and post stools samples were collected, and validated questionnaires used to measure change in social and mealtime behaviours, GI symptoms and pQOL...
January 31, 2024: Journal of Autism and Developmental Disorders
https://read.qxmd.com/read/38287844/probiotics-and-prebiotics-in-the-treatment-of-autism-spectrum-disorder-a-narrative-review
#40
REVIEW
Si Zhang, Fei Han, Qiong Wang, Fei Fan
More than half of the patients with autism spectrum disorder (ASD) have gastrointestinal (GI) comorbidities, such as constipation, indigestion, abdominal pain, and diarrhea. Recent studies suggest prescribing probiotics and prebiotics in ASD could relieve GI disturbances and behavioral issues. This narrative review generalizes the research progress on probiotic and prebiotic therapies for ASD over the past 5 years and further discusses the underlying mechanisms of interaction between probiotics and prebiotics with ASD...
January 22, 2024: Journal of Integrative Neuroscience
keyword
keyword
95737
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.